Category: Press Releases

TrueBinding Highlights the Potential of TB006’s Unique Mechanism of Action as a Novel Approach for the Treatment of Alzheimer’s Disease at the 15th Clinical Trials on Alzheimer’s Disease (CTAD) Conference

Novel antibody, TB006, demonstrated improvements in cognition and function and was well tolerated in a one-month Phase 1b/2 trial in mild to severe Alzheimer’s disease (AD) patients TB006 also demonstrated improvements in PET and MR imaging, consistent with dissolution of toxic amyloid plaque shown in preclinical studies Ongoing open-label extension study with more than 100 […]

TrueBinding Highlights the Potential of TB006’s Unique Mechanism of Action as a Novel Approach for the Treatment of Alzheimer’s Disease at the 15th Clinical Trials on Alzheimer’s Disease (CTAD) Conference

Novel antibody, TB006, demonstrated improvements in cognition and function and was well tolerated in a one-month Phase 1b/2 trial in mild to severe Alzheimer’s disease (AD) patients TB006 also demonstrated improvements in PET and MR imaging, consistent with dissolution of toxic amyloid plaque shown in preclinical studies Ongoing open-label extension study with more than 100 […]

Jeito Capital strengthens its support in Pulmocide with participation in $52 million financing

Jeito Capital strengthens its support in Pulmocide with participation in $52 million financing The Series C extension round will accelerate clinical development, manufacturing scale-up and pre-commercialization activities of Pulmocide’s lead product candidate, opelconazole Paris, France, December 6th 2022 – Jeito Capital (“Jeito”), the largest fully independent international private equity firm dedicated to healthcare and biopharma, announced today its participation in a $52 million Series C extension financing round in portfolio company […]

Jeito Capital strengthens its support in Pulmocide with participation in $52 million financing

Jeito Capital strengthens its support in Pulmocide with participation in $52 million financing The Series C extension round will accelerate clinical development, manufacturing scale-up and pre-commercialization activities of Pulmocide’s lead product candidate, opelconazole Paris, France, December 6th 2022 – Jeito Capital (“Jeito”), the largest fully independent international private equity firm dedicated to healthcare and biopharma, announced today its participation in a $52 million Series C extension financing round in portfolio company […]

The Passport Index reveals that Despite Conflict in Europe and Global Border Anxieties, 99.5% of the World Experiences Growth in Global Mobility in 2022

MONTREAL, Dec. 06, 2022 (GLOBE NEWSWIRE) — The Passport Index has published its latest update today, showing that global mobility is rising, despite the eruption of conflict in Europe and growing tensions over borders. Though the world continues to feel the aftershocks of the pandemic, surprisingly, traveling has never been easier, with steady growth in passport […]

The Passport Index reveals that Despite Conflict in Europe and Global Border Anxieties, 99.5% of the World Experiences Growth in Global Mobility in 2022

MONTREAL, Dec. 06, 2022 (GLOBE NEWSWIRE) — The Passport Index has published its latest update today, showing that global mobility is rising, despite the eruption of conflict in Europe and growing tensions over borders. Though the world continues to feel the aftershocks of the pandemic, surprisingly, traveling has never been easier, with steady growth in passport […]